Increase probability of success in chronic disease drug discovery, clinical development & product launch in this seminar from PrecisionLifeAbout this Event
Date: Thursday, Sep 26, 2024
Time: 09:00 PDT
Location: The Lighthouse, 685, Gateway Blvd, South San Francisco, CA
Join us for a deep dive into precision medicine for chronic disease R&D. Learn about the latest advancements in using artificial intelligence to uncover causal relationships and stratify patients based on mechanistic insights, and gain valuable knowledge to drive innovation in your own projects.
A new era of precision medicine possibilities
This event is a unique opportunity to hear from PrecisionLife, the clinical-stage precision medicine company for chronic diseases, about the application of mechanistic stratification and causal AI to inform and significantly de-risk each stage of R&D.
Join PrecisionLife CEO, Steve Gardner, and guests to learn more about novel mechanism-based biomarkers and how they are being used to design and de-risk clinical trials, identify valuable label extension opportunities, and build precision medicine-ready programs for chronic diseases including CNS, neurodegenerative, cardiovascular, metabolic, autoimmune, respiratory and psychiatric disorders.
Not knowing which patients will respond to which drugs is a major cause of drug development risk and healthcare inefficiency. By completely reimagining how to analyze patient data we can now better understand causal biology to increase the probability of success in drug discovery, clinical development, and product launch.
The event is designed for those committed to finding better, more personalized treatment and diagnostic options for people with unmet medical needs. Particularly professionals in strategic roles or in business development and licensing, translational research, and clinical development.
Event Venue
The Lighthouse, 685 Gateway Boulevard, South San Francisco, United States
USD 0.00